Laboratorios Farma | ROVI - 营业利润

股票价格

80.85

每天变化

-1.80 -2.18%

每月一次

0.68%

每年

68.23%

Q2 预测

80.24

金融业

EUR

EUR 799.88M

现金及等价物

EUR 46.11M

EUR 186.09M

EUR 509.33M

EUR 199.84M

EUR 129.3M

股息收益率

2.15

EUR 135.05M

EUR 34.94M

1.99K

EPS每股收益

EUR 1.96

股本和储备

EUR 539.39M

EUR 105.28M

债务利息支出

EUR 699K

EUR 139K

EUR 80.5M

EUR 4.17B

EUR 103.69M

EUR 313.62M

EUR 135.05M

普通股股本

EUR 51.82M

18.78

EUR 26.78M

EUR 448.66M

销售和管理费用

EUR 35.32M

EUR 327.67M

贸易债权人

EUR 107.59M

应收帐款人

EUR 143.38M

	营业利润	更改		日
Akebia Therapeutics	USD -5.45M		9.4M	2025-12
Alaunos Therapeutics	USD -1.19M		148K	2025-09
Almirall	EUR 30.23M		12.8M	2025-12
Avita Medical	AUD -10.41M		742K	2025-12
Dianthus Therapeutics	USD -69.54M		29.25M	2025-12
Ionis Pharmaceuticals	USD -215M		54.82M	2025-12
IQVIA Holdings	USD 2.68B		2.1B	2025-12
Laboratorios Farma	EUR 135.05M		49.84M	2023-12
Moderna	USD -857M		597M	2025-12
Organon & Co	USD 388M		62M	2025-09
Pharma Mar	EUR 43.61M		47.57M	2025-12
Revvity	USD 145.83M		47.49M	2025-12
Tectonic Therapeutic	USD -21.52M		374K	2025-12
Viatris	USD -157.5M		392M	2025-12
Xeris Pharmaceuticals	USD 16.77M		10.04M	2025-12